Employers › Angiotech Pharmaceuticals (US)
Recordkeeping fees per participant · Corza Medical 401(k) Plan · plan year 2024
$78.81
Higher than 48% of the 14,075 plans $10 to 50M that report it.
= $34,362 / 436
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250930075718NAL0019027234001, received 2025-09-30
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250930075718NAL0019027234001, received 2025-09-30
Percentiles compare this plan with the Schedule H plans $10 to 50M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-09-30.
Administrative expenses excluding investment management, per participant
$123.31
Higher than 52% of the 24,371 plans $10 to 50M that report it.
= $53,762 / 436
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250930075718NAL0019027234001, received 2025-09-30
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250930075718NAL0019027234001, received 2025-09-30
Administrative expenses per participant
$227.63
Higher than 57% of the 25,098 plans $10 to 50M that report it.
= $99,245 / 436
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250930075718NAL0019027234001, received 2025-09-30
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250930075718NAL0019027234001, received 2025-09-30
Administrative expenses as a share of assets
0.273%
Higher than 47% of the 25,132 plans $10 to 50M that report it.
= $99,245 / $36,331,796
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250930075718NAL0019027234001, received 2025-09-30
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250930075718NAL0019027234001, received 2025-09-30
Employer contributions per participant
$3,292
Higher than 77% of the 24,050 plans $10 to 50M that report it.
= $1,435,431 / 436
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250930075718NAL0019027234001, received 2025-09-30
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250930075718NAL0019027234001, received 2025-09-30
Employer share of total contributions
27.6%
Higher than 49% of the 24,084 plans $10 to 50M that report it.
= $1,435,431 / $5,205,235
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250930075718NAL0019027234001, received 2025-09-30
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250930075718NAL0019027234001, received 2025-09-30
Plan terms are not published in public filings.
2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2T default investment (QDIA) · 3D IRS pre-approved plan · 3H controlled-group sponsor · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250930075718NAL0019027234001, received 2025-09-30
| Field | Value | Source |
|---|---|---|
| Plan sponsor | CORZA MEDICAL INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Plan name | CORZA MEDICAL 401(K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Sponsor EIN / plan number | 91-2089490 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Sponsor location | WESTWOOD, MA | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Industry (business code) | 325410, Manufacturing | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Filing received | 2025-09-30 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Participants, beginning of year | 570 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Active participants | 371 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Participants, end of year | 565 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Participants with an account balance | 436 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Total assets, beginning of year | $35,892,715 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Total assets, end of year | $36,331,796 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Net assets, end of year | $36,312,396 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Total income | $9,108,760 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Net income | $438,931 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Employer contributions | $1,435,431 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Participant contributions | $3,055,465 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Other contributions (incl. rollovers) | $714,339 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Total contributions | $5,205,235 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Benefit payments | $8,559,456 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Total expenses (incl. benefit payments) | $8,669,829 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Total administrative expenses | $99,245 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Recordkeeping fees | $34,362 | Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| IQPA audit fees | $19,400 | Schedule H, line 2i(4); IQPA_AUDIT_FEES_AMT pos 161; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Investment advisory and management fees | $45,483 | Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Administrative expenses excluding investment management | $53,762 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Held in common/collective trusts | $0 | Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Held in mutual funds | $33,104,117 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250930075718NAL0019027234001, received 2025-09-30 |
| Independent auditor | WIPFLI,LLP | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250930075718NAL0019027234001, received 2025-09-30 |
Position = column in the DOL layout for form year 2024. Filing 20250930075718NAL0019027234001, received 2025-09-30.
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| GLOBAL RETIREMENT PARTNERS LLC | NONE | 28 Investment management; 50 Direct payment from the plan | $44,153 | no |
| SCHWAB RETIREMENT PLAN SERVICES,INCrecordkeeper | NONE | 15 Recordkeeping and information management; 26 Investment advisory (participants); 50 Direct payment from the plan; 64 Recordkeeping fees | $35,842 | no |
| WIPFLI LLP | NONE | 10 Accounting (including auditing); 50 Direct payment from the plan | $19,250 | no |
| CHARLES SCHWAB & CO., INC. | NONE | 33 Securities brokerage; 50 Direct payment from the plan; 62 Float revenue; 71 Securities brokerage commissions and fees | $41 | yes |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250930075718NAL0019027234001, received 2025-09-30.
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $35,892,715 | $36,331,796 | 1.2% |
| Participants with a balance | 439 | 436 | -0.7% |
| Administrative expenses | $111,687 | $99,245 | -11.1% |
| Recordkeeping fees per participant | $31.88 | $78.81 | 147.2% |
| Employer contributions | $1,331,573 | $1,435,431 | 7.8% |
Prior filing 20241015120100NAL0029511009003, received 2024-10-15; the plan years are contiguous.
Sponsor name as filed: CORZA MEDICAL INC.; SEC registrant: Angiotech Pharmaceuticals (US), Inc. (CIK 1374509, matched by EIN).